Jul 22, 2022 / 07:30AM GMT
Operator
Good morning, and welcome to the BioGaia Conference Call. (Operator Instructions) Please note this event is being recorded.
I'd now like to turn the conference over to Isabelle Ducellier, CEO. Thank you, and over to you, ma'am.
Isabelle Valerie Ghislaine Ducellier - BioGaia AB(publ)-CEO&President
Thank you, and good morning, everybody. So following a very strong quarter -- first quarter, I'm actually very pleased to present yet another very strong quarter with sales up with 42%, mainly driven by strong growth in Europe and with plus 26% organic growth. I mean we are pretty proud to say that we outperformed the probiotics market during this quarter. In terms of EBIT, thanks to close cost monitoring, we can here as well present strong figures with an increase of 46%. And to end up this executive summary, it's worth mentioning a strong operating cash flow at SEK 87 million.
Next page, please. Looking at key events, I just would like to have your attention on the press release we found on 17th
Q2 2022 Biogaia AB Earnings Call Transcript
Feb 12, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers